TABLE 2.
Activities of PA-824 and TBA-354 in a continuation phase model in experiment 2
Treatment (dose [mg/kg]) | Mean ± SD lung log10 CFU on: |
||||
---|---|---|---|---|---|
Day −42 | Day 0 | Wk 4 | Wk 8 | Wk 12 | |
Day 0 to wk 4 | |||||
RHZ | 2.97 ± 0.02 | 7.00 ± 0.14 | 3.58 ± 0.25 | ||
Wk 4 to 12 | |||||
None | 4.94 ± 0.34 | ||||
RH | 0.80 ± 0.28 | ||||
PA-824 (50) | 3.19 ± 0.33 | 2.47 ± 0.06 | |||
TBA-354 (10) | 2.65 ± 0.15 | 2.10 ± 0.08 |